Gulf International Bank (UK)’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,146
Closed -$923K 704
2022
Q1
$923K Hold
12,146
0.01% 596
2021
Q4
$1.81M Hold
12,146
0.03% 537
2021
Q3
$1.77M Hold
12,146
0.02% 566
2021
Q2
$2.38M Hold
12,146
0.03% 521
2021
Q1
$2.2M Sell
12,146
-3,267
-21% -$564K 0.03% 517
2020
Q4
$2.18M Buy
+15,413
New +$2.24M 0.03% 534

Other funds holding TXG

Gulf International Bank (UK)'s TXG Position: Q2 2022 in Review

Gulf International Bank (UK) sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 12,146 shares — an estimated $923K sold.

Gulf International Bank (UK) first reported a position in TXG in Q4 2020 and held it in 6 quarters. The position peaked at $2.38M in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Gulf International Bank (UK) reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Gulf International Bank (UK) sold 12,146 10x Genomics shares in Q2 2022, an estimated $923K.
  • Gulf International Bank (UK) first reported a position in 10x Genomics in Q4 2020 and held it in 6 quarters.
  • Gulf International Bank (UK)'s 10x Genomics position peaked at $2.38M in Q2 2021.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Gulf International Bank (UK)'s 13F filing for Q2 2022, filed 19 Jul 2022.